Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Ionis Pharmaceuticals | IONS - Biaya Operasional
Keuangan
Harga Saham
USD
Aktiva
USD 2.99B
Kas Dan Setara
USD 350.07M
Biaya Penjualan
USD 2.74M
Aset Lancar
USD 2.49B
Kewajiban Lancar
USD 315.64M
UTANG
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
Karyawan
1.07K
Eps Laba Per Saham
USD -0.69
Modal Dan Cadangan
USD 439.74M
Laba Kotor Pada Penjualan
USD 265M
Beban Bunga Utang
USD 18M
Pendapatan Bunga
USD -0.66
Modal Pinjaman
USD 1.91B
Kapitalisasi Pasar
USD 9.21B
Batas Pemasukan
USD -114.65M
Biaya Operasional
USD 370.24M
Laba Operasional
USD -102.29M
Modal Saham Biasa
USD 165.64M
Pe Harga Untuk Laba
396.15
Laba Sebelum Pajak
USD -114M
Pendapatan Penjualan
USD 268M
Beban Penjualan Dan Administrasi
USD 130.08M
Saham
USD 50.83M
Kreditur Perdagangan
USD 47.7M
Debitur Perdagangan
USD 58.85M
Biaya Operasional
Perubahan
Tanggal
Agios Pharmaceuticals
USD 130.77M
10.77M
2026-03
Alnylam Pharmaceuticals
USD 1.06B
160.97M
2026-06
Arrowhead Research
USD 245.35M
30.35M
2026-06
Astellas Pharma
JPY 455.56B
33.8B
2026-06
BioCryst Pharmaceuticals
USD 119.78M
673.63M
2026-06
BioMarin Pharmaceutical
USD 6.32B
5.69B
2026-06
Celltrion
KRW 119.22B
21.46B
2026-03
Cspc Pharmaceutical
CNY 5.91B
512.77M
2025-12
Deva Holding AS
TRY 1.35B
178.26M
2023-09
Divis Laboratories Ltd
INR 19.51B
660M
2026-06
Exelixis
USD 380.28M
20.8M
2026-06
Halozyme Therapeutics
USD 193.34M
1.15M
2026-06
Ionis Pharmaceuticals
USD 370.24M
6.24M
2026-06
Kangmei Pharma
CNY 1.09B
304.02M
2026-03
Knight Therapeutics
CAD 126.9M
8.29M
2025-12
Laboratorios Farma
EUR 313.62M
17.98M
2023-12
Malin Corporation
EUR 1.1M
400K
2024-12
Medical Developments International
AUD 21.61M
11.59M
2025-12
Moderna
USD 960M
817M
2026-06
Nektar Therapeutics
USD 49.12M
8.22M
2026-03
Neuren Pharmaceuticals
AUD 25.23M
16.54M
2025-12
Neurocrine Biosciences
USD 739.1M
139.2M
2026-06
Novartis
USD 10.2B
912M
2026-06
Omeros
USD 59.16M
20.13M
2024-06
OPKO Health
USD 175.21M
11.55M
2026-03
Organigram Holdings
CAD 69.59M
14.08M
2026-03
Ovoca Bio
EUR 173K
990K
2025-12
Pfizer
USD 85.19B
4.91B
2026-06
Pharma Mar
EUR 51.01M
8.73M
2026-06
PTC Therapeutics
USD 226.66M
19.64M
2026-03
Qiagen NV
USD 393.64M
17.95M
2026-06
Regeneron Pharmaceuticals
USD 31.71B
287.8M
2026-06
Roche Holding
CHF 18.9B
2.12B
2026-06
Sarepta Therapeutics
USD 387.96M
15.59M
2026-06
Sartorius
EUR 747.8M
9.4M
2026-06
Sino Biopharmaceutical
CNY 12.39B
1.26B
2025-06
Tilray
USD 237.52M
17.34M
2025-09
Ultragenyx Pharmaceutical
USD 289M
16M
2026-06
Vertex Pharmaceuticals
USD 2.07B
217.1M
2026-06
Zealand Pharma A/S
573M
202.97M
2026-03
Zz Pientze Pharmaceu
CNY 1.88B
326.34M
2026-03
×